Patents by Inventor Susanne Berchtold

Susanne Berchtold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9795643
    Abstract: The present invention pertains to a pharmaceutical composition comprising a recombinant measles virus encoding a suicide gene for use in the treatment of malignant cells with primary or secondary resistances against an oncolytic measles virus without suicide gene activity. Further, the present invention pertains to a recombinant measles virus based on measles vaccine strain Schwarz encoding a suicide gene, which comprises a fusion of a cytosine deaminase, particularly yeast cytosine deaminase, and a uracil phosphoribosyltransferase, particularly yeast uracil phosphoribosyltransferase, to a method and a kit for preparing the recombinant measles virus as claimed herein.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: October 24, 2017
    Inventors: Ulrich M. Lauer, Michael Bitzer, Johanna Lampe, Martina Schell, Susanne Berchtold, Sebastian Lange, Wolfgang J. Neubert, Sascha Bossow
  • Patent number: 9272008
    Abstract: The present invention pertains to a pharmaceutical composition comprising a recombinant measles virus encoding a suicide gene for use in the treatment of malignant cells with primary or secondary resistances against an oncolytic measles virus without suicide gene activity. Further, the present invention pertains to a recombinant measles virus based on measles vaccine strain Schwarz encoding a suicide gene, which comprises a fusion of a cytosine deaminase, particularly yeast cytosine deaminase, and a uracil phosphoribosyltransferase, particularly yeast uracil phosphoribosyltransferase, to a method and a kit for preparing the recombinant measles virus as claimed herein.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: March 1, 2016
    Inventors: Ulrich M. Lauer, Michael Bitzer, Johanna Lampe, Martina Zimmermann, Susanne Berchtold, Sebastian Lange, Wolfgang J. Neubert, Sascha Bossow
  • Publication number: 20150250838
    Abstract: The present invention pertains to a pharmaceutical composition comprising a recombinant measles virus encoding a suicide gene for use in the treatment of malignant cells with primary or secondary resistances against an oncolytic measles virus without suicide gene activity. Further, the present invention pertains to a recombinant measles virus based on measles vaccine strain Schwarz encoding a suicide gene, which comprises a fusion of a cytosine deaminase, particularly yeast cytosine deaminase, and a uracil phosphoribosyltransferase, particularly yeast uracil phosphoribosyltransferase, to a method and a kit for preparing the recombinant measles virus as claimed herein.
    Type: Application
    Filed: May 22, 2015
    Publication date: September 10, 2015
    Inventors: Ulrich M. LAUER, Michael BITZER, Johanna LAMPE, Martina ZIMMERMANN, Susanne BERCHTOLD, Sebastian LANGE, Wolfgang J. NEUBERT, Sascha BOSSOW
  • Publication number: 20130217757
    Abstract: The present invention pertains to a pharmaceutical composition comprising a recombinant measles virus encoding a suicide gene for use in the treatment of malignant cells with primary or secondary resistances against an oncolytic measles virus without suicide gene activity. Further, the present invention pertains to a recombinant measles virus based on measles vaccine strain Schwarz encoding a suicide gene, which comprises a fusion of a cytosine deaminase, particularly yeast cytosine deaminase, and a uracil phosphoribosyltransferase, particularly yeast uracil phosphoribosyltransferase, to a method and a kit for preparing the recombinant measles virus as claimed herein.
    Type: Application
    Filed: August 19, 2011
    Publication date: August 22, 2013
    Inventors: Ulrich M. Lauer, Michael Bitzer, Johanna Lampe, Martina Zimmermann, Susanne Berchtold, Sebastian Lange, Wolfgang J. Neubert, Sascha Bossow